Showing 1 posts of 1 posts found.
Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO